US2016053316A1PendingUtilityA1
Systems and Methods for Determining a C-Peptide Receptor, C-Peptide Receptor, and Methods of Using Same
Est. expirySep 4, 2032(~6.1 yrs left)· nominal 20-yr term from priority
Inventors:Gina L. C. Yosten
C12Q 1/6876C07K 16/28G01N 33/566C12Q 2600/158G01N 2333/726G01N 33/68A61K 39/3955C07K 2317/76A61K 38/28
37
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Systems and methods for the determination of a peptide receptor and use of it to provide a therapeutic C-peptide sensitizer. Specifically to determine a receptor for any peptide provided that the receptor is a G protein coupled receptor (GPCR).
Claims
exact text as granted — not AI-modified1 . A method for C-peptide therapy comprising:
for a particular patient, screening a plurality of different biological matters expected to be responsive to C-peptide for G protein coupled receptor (GPCR) expression; identifying an expressed GPCR which is produced in majority of said plurality of biological matters responsive to C-peptide treatment; and testing said GPCR for responsiveness, if it is responsive, then
selecting a C-peptide sensitizer based on the GPCR identified; and
supplying a therapeutic amount of said C-peptide sensitizer along with C-peptide to said patient.
2 . The method of claim 1 wherein said GPCR is GPR19.
3 . The method of claim 1 wherein said GPCR is GPR146.
4 . The method of claim 4 wherein C-peptide sensitizer is anti-GPR146ex.Join the waitlist — get patent alerts
Track US2016053316A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.